drugset / Trial / NCT01131624
Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women
RandomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to look at how well Ferric Carboxymaltose, an intravenous iron therapy (iron that is infused directly into your body through a vein), compares with ferrous sulphate capsules taken by mouth in the treatment of iron deficiency anaemia during pregnancy.
Timeline
- Start
- 2010-05
- Primary completion
- 2014-05
- Completion
- 2015-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ferric carboxymaltose | Other / unclassified | 1000 mg | Intravenous |
| Comparator | Ferric carboxymaltose | Other / unclassified | 1500 mg | Intravenous |
| Comparator | Ferrous Sulfate | Diagnostic / imaging agent | 200 mg | Oral |